DaVita Inc.
DVALast close · Oct 16, 2026187.31−1.85 (−0.98%)
Market cap$12.0B
5 firms' latest targets, last 90 days: median $220.00 ($215.00–$265.00), 17% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-08-07 | Truist | $215.00 | ▼ 14% | +15% |
| 2026-08-07 | Oppenheimer | $220.00 | — | +17% |
| 2026-08-07 | Raymond James | $220.00 | — | +17% |
| 2026-08-05 | Deutsche Bank | $265.00 | ▲ 20% | +41% |
| 2026-08-05 | Barclays | $224.00 | ▲ 3% | +20% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2022reported | $11.6B | +0% | $5.85 | -34% | est. $11.6B+0% | est. $6.21 | 1 |
| 2023reported | $12.1B | +5% | $7.42 | +27% | est. $12.0B+1% | est. $7.98 | 5 |
| 2024reported | $12.8B | +6% | $10.73 | +45% | est. $12.8B+0% | est. $9.68 | 5 |
| 2025reported | $13.6B | +6% | $9.84 | -8% | est. $13.5B+1% | est. $10.56 | 5 |
| 2026 | $14.1B | +3% | $14.83 | +40% | $14.0B–$14.3B | $13.54–$15.80 | 5 |
| 2027 | $14.5B | +3% | $16.96 | +14% | $14.3B–$15.0B | $16.73–$17.10 | 5 |
| 2028 | $15.0B | +3% | $19.54 | +15% | $14.3B–$15.9B | $18.92–$20.71 | 5 |
| 2029 | $15.9B | +6% | $18.12 | -7% | $15.5B–$16.4B | $17.53–$18.93 | 2 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.